Double-blind, Placebo Controlled, Randomized Multiple Ascending Dose Study in Fed Conditions for Ten Days Dosing Regimen With a Loading Dose to Evaluate the Safety, the Tolerability and the Pharmacokinetics of Oral Fexinidazole in 36 Healthy Male Sub-Saharan Volunteers.

Trial Profile

Double-blind, Placebo Controlled, Randomized Multiple Ascending Dose Study in Fed Conditions for Ten Days Dosing Regimen With a Loading Dose to Evaluate the Safety, the Tolerability and the Pharmacokinetics of Oral Fexinidazole in 36 Healthy Male Sub-Saharan Volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Fexinidazole (Primary)
  • Indications African trypanosomiasis
  • Focus Adverse reactions
  • Sponsors Drugs for Neglected Diseases Initiative Foundation
  • Most Recent Events

    • 14 Apr 2014 New trial record
    • 18 Feb 2014 Results published in Clinical Pharmacokinetics.
    • 10 Feb 2014 According to ClinicalTrials.gov record, status changed from recruiting to terminated due to poor tolerability at highest dose.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top